Astellas CEO Yasukawa On Enabling Faster R&D
TPDs One Beneficiary
Executive Summary
Keeping the company focus on launching innovating drugs, Astellas CEO Kenji Yasukawa talks in part one of this exclusive interview on how the Japanese firm transformed its R&D processes to allow more flexible and agile decision-making beyond the wall of multiple sections.